Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)-Pitfalls of Routine Application.

Maximilian KittelRomy EichnerSihem AidaAnna BodeVolker AstAnja KesslerMichael NeumaierRoman Wölfel Verena Haselmann

Published in: Viruses (2022)

This EQA revealed serious concerns regarding the reliability and appropriate use of anti-SARS-CoV-2 antibody assays in routine care. In addition to the wide heterogeneity of different assays used by participating laboratories, a lack of standardization and harmonization is also evident. This is of particular importance for reliable and clinically meaningful interpretation of test results.

Keyphrases

sars cov
respiratory syndrome coronavirus
clinical practice
single cell
high throughput
healthcare
palliative care
pain management
loop mediated isothermal amplification
coronavirus disease
affordable care act